HTG Molecular Diagnostics Inc. (NASDAQ:HTGM) went up by 14.95% from its latest closing price compared to the recent 1-year high of $6.98. The company’s stock price has collected 8.85% of gains in the last five trading sessions.
Is It Worth Investing in HTG Molecular Diagnostics Inc. (NASDAQ :HTGM) Right Now?
Plus, the 36-month beta value for HTGM is at 1.34. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for HTG Molecular Diagnostics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $3.25, which is $2.52 above the current price. Today, the average trading volume of HTGM was 3.71M shares.
HTGM’s Market Performance
HTGM stocks went up by 8.85% for the week, with a monthly jump of 0.82% and a quarterly performance of 44.71%, while its annual performance rate touched -80.38%. The volatility ratio for the week stands at 14.29% while the volatility levels for the past 30 days are set at 20.70% for HTG Molecular Diagnostics Inc. The simple moving average for the period of the last 20 days is -6.75% for HTGM stocks with a simple moving average of -49.90% for the last 200 days.
Analysts’ Opinion of HTGM
Rodman & Renshaw gave a rating of “Buy” to HTGM, setting the target price at $6 in the report published on May 16th of the previous year.
HTGM Trading at 34.41% from the 50-Day Moving Average
After a stumble in the market that brought HTGM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.38% of loss for the given period.
Volatility was left at 20.70%, however, over the last 30 days, the volatility rate increased by 14.29%, as shares sank -12.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +119.64% upper at present.
During the last 5 trading sessions, HTGM rose by +8.85%, which changed the moving average for the period of 200-days by -78.35% in comparison to the 20-day moving average, which settled at $1.3105. In addition, HTG Molecular Diagnostics Inc. saw -77.31% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for HTGM
Current profitability levels for the company are sitting at:
- -205.48 for the present operating margin
- +54.02 for the gross margin
The net margin for HTG Molecular Diagnostics Inc. stands at -192.49. Equity return is now at value -136.70, with -57.50 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.73.